Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Presentation will be Webcast Live and Archived on Vanda's Website
WASHINGTON, Feb. 27, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that Mihael Polymeropoulos , M.D., Vanda's President and CEO, will deliver a corporate presentation at the Cowen and Company 33rd Annual Health Care Conference in Boston on Monday, March 4, 2013 at 4:50 p.m. Eastern Time.
The presentation will be webcast live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at http://www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Company Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.
RELATED LINKS
http://www.vandapharma.com
More by this Source
Vanda Pharmaceuticals Reports First Quarter 2013 Results
May 09, 2013, 06:55 ET
Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Apr 18, 2013, 07:00 ET
Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
Apr 17, 2013, 19:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.